These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1120 related articles for article (PubMed ID: 14609222)

  • 21. Dendritic cells and their role in cancer immunotherapy.
    Jalili A
    Iran J Immunol; 2007 Sep; 4(3):127-44. PubMed ID: 17767012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.
    Ueda Y; Itoh T; Nukaya I; Kawashima I; Okugawa K; Yano Y; Yamamoto Y; Naitoh K; Shimizu K; Imura K; Fuji N; Fujiwara H; Ochiai T; Itoi H; Sonoyama T; Hagiwara A; Takesako K; Yamagishi H
    Int J Oncol; 2004 Apr; 24(4):909-17. PubMed ID: 15010829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
    Santin AD; Bellone S; Palmieri M; Ravaggi A; Romani C; Tassi R; Roman JJ; Burnett A; Pecorelli S; Cannon MJ
    Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
    Ackermann B; Tröger A; Glouchkova L; Körholz D; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(3):176-82. PubMed ID: 15175963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells.
    Breckpot K; Heirman C; Neyns B; Thielemans K
    J Gene Med; 2004 Nov; 6(11):1175-88. PubMed ID: 15468193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current issues in dendritic cell cancer immunotherapy.
    López JA; Hart DN
    Curr Opin Mol Ther; 2002 Feb; 4(1):54-63. PubMed ID: 11885565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic vaccine generated by electrofusion of dendritic cells and tumour cells.
    Kuriyama H; Shimizu K; Lee W; Kjaergaard J; Parkhurst MR; Cohen PA; Shu S
    Dev Biol (Basel); 2004; 116():169-78; discussion 179-86. PubMed ID: 15603192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer vaccines for established cancer: how to make them better?
    Andrews DM; Maraskovsky E; Smyth MJ
    Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guiding the "misguided" - functional conditioning of dendritic cells for the DC-based immunotherapy against tumours.
    Huang FP; Chen YX; To CK
    Eur J Immunol; 2011 Jan; 41(1):18-25. PubMed ID: 21182072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
    Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2004; 18(1):81-100. PubMed ID: 15011756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of immunity and tolerance in renal diseases].
    Ranieri E
    G Ital Nefrol; 2005; 22(2):140-51. PubMed ID: 15875277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H; Shurin MR; Han B
    Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression.
    Jin O; Kavikondala S; Sun L; Fu R; Mok MY; Chan A; Yeung J; Lau CS
    Lupus; 2008 Jul; 17(7):654-62. PubMed ID: 18625638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus.
    Decker P; Kötter I; Klein R; Berner B; Rammensee HG
    Rheumatology (Oxford); 2006 Sep; 45(9):1087-95. PubMed ID: 16527880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation.
    Lee JJ; Kook H; Park MS; Nam JH; Choi BH; Song WH; Park KS; Lee IK; Chung IJ; Hwang TJ; Kim HJ
    J Clin Apher; 2004; 19(2):66-70. PubMed ID: 15274198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate.
    Soleimani A; Berntsen A; Svane IM; Pedersen AE
    Scand J Immunol; 2009 Nov; 70(5):481-9. PubMed ID: 19874553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18.
    Tucci M; Quatraro C; Lombardi L; Pellegrino C; Dammacco F; Silvestris F
    Arthritis Rheum; 2008 Jan; 58(1):251-62. PubMed ID: 18163476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N; Moazzeni SM; Shokri F; Shokrgozar MA; Atri M; Kokhaei P
    Cell Immunol; 2009; 257(1-2):23-31. PubMed ID: 19306994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.